Press-release for stocks for amgen inc. for AZNCF

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | News | $138.24 -4.19% 800

| 0.19% | O: 2.1% H: 0.0% C: -2.52%
NVS | $94.36 1.93% 0.0% 2.3M

| 0.17% | O: -1.46% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -1.85% | O: -1.19% H: 0.52% C: -0.17%
BAX | $39.47 -0.45% 0.0% 2.8M

| -1.42% | O: -0.1% H: 0.13% C: -1.08%
ABBV | $166.41 1.06% 0.0% 5.5M

| 2.93% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -1.22% | O: -2.13% H: 0.0% C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M

| -3.15% | O: -0.72% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| -0.26% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M

| 1.29% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | News | $138.24 -4.19% 800

| 1.11% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M

| -1.59% | O: 0.52% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -7.54% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.93 1.3% 0.0% 10M

| -8.11% | O: 0.26% H: 2.03% C: 1.57%
ABBV | $166.41 1.06% 0.0% 5.5M

| -7.73% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $107.28 1.91% 0.18% 10M

| -4.27% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -6.88% | O: -0.96% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 0.42% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $269.03 2.39% 2.33% 3.4M

| -6.07% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| 5.38% | O: 3.21% H: 0.0% C: -1.71%
NVS | $94.36 1.93% 0.0% 2.3M

| -5.57% | O: 0.08% H: 0.86% C: 0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -7.57% | O: -0.68% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| -6.9% | O: -0.02% H: 0.0% C: -2.29%
ABT | News | $107.28 1.91% 0.18% 10M

| -10.67% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -3.74% | O: -0.08% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 3.57% | O: -0.03% H: 0.62% C: 0.5%
AMGN | $269.03 2.39% 2.33% 3.4M

| -1.44% | O: -0.02% H: 1.37% C: 0.34%
company report global market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.24 -4.19% 800

| 7.24% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 26.78% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 -1.11% 520K

| -14.57% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -10.18% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.36 1.93% 0.0% 2.3M

| -8.0% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -5.22% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| -2.63% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.93 1.3% 0.0% 10M

| -3.89% | O: -0.65% H: 1.63% C: 1.48%
ABBV | $166.41 1.06% 0.0% 5.5M

| -5.63% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -1.76% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 5.32% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $269.03 2.39% 2.33% 3.4M

| -5.13% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M

| Email alert Add to watchlist
VTRS A | $11.25 1.17% 1.16% 4.7M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510

| Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M

| Email alert Add to watchlist
AZNCF | News | $138.24 -4.19% 800

| Email alert Add to watchlist
JAZZ | $109.96 0.63% 0.63% 760K

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M

| Email alert Add to watchlist
cancer cell global growth market

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6

| 9.6% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | News | $20.2 -14.18% 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 600K

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

Professional, Scientific, and T...

| 10.28% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $55.65 0.02% 32K

| 11.08% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $544.78 0.6% 0.0% 1.7M

| 1.15% | O: 0.56% H: 1.3% C: 1.22%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -7.67% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -6.21% | O: -0.91% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -3.96% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| -2.24% | O: 0.38% H: 2.44% C: 1.54%
BAX | $39.47 -0.45% 0.0% 2.8M

| -0.38% | O: 0.33% H: 0.63% C: -0.28%
ABBV | $166.41 1.06% 0.0% 5.5M

| -4.61% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

| -4.7% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $46.32 2.05% 2.01% 3.3M

| 0.28% | O: -1.1% H: 0.0% C: 0.0%
GLPG | News | $29.095 0.64% 0.64% 87K

| -25.55% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $194.39 2.03% 1.99% 1.6M

| -14.24% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 12.32% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $269.03 2.39% 2.33% 3.4M

| -7.42% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 -2.18% 600K

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

| 10.28% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -3.96% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| -2.24% | O: 0.38% H: 2.44% C: 1.54%
VRTX | News | $394.43 0.24% 0.24% 1.3M

| -5.23% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $46.32 2.05% 2.01% 3.3M

| 0.28% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M

| -14.24% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 12.32% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $269.03 2.39% 2.33% 3.4M

| -7.42% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.24 -4.19% 800

| 12.87% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.47 -1.11% 520K

| -12.2% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -7.48% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M

| -6.14% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -5.55% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -3.21% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| -1.49% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.93 1.3% 0.0% 10M

| -1.65% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M

| -3.85% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K

| -22.73% | O: -1.15% H: 1.03% C: -1.5%
VRTX | News | $394.43 0.24% 0.24% 1.3M

| -5.79% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M

| 0.22% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

| -5.43% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.3 -0.98% -0.99% 2.2M

| -9.49% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $194.39 2.03% 1.99% 1.6M

| -20.58% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 11.63% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $360.11 0.47% 0.47% 330K

| -8.27% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $269.03 2.39% 2.33% 3.4M

| -8.66% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| 10.28% | O: -0.57% H: 0.04% C: -1.74%
NVS | $94.36 1.93% 0.0% 2.3M

| -6.6% | O: -1.46% H: 1.04% C: 0.97%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| -1.87% | O: 0.09% H: 0.0% C: -0.48%
BMY | $48.93 1.3% 0.0% 10M

| -1.77% | O: 0.02% H: 0.46% C: -0.14%
ABBV | $166.41 1.06% 0.0% 5.5M

| -4.91% | O: -0.83% H: 0.7% C: -0.27%
ABT | News | $107.28 1.91% 0.18% 10M

| -4.43% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -0.64% | O: -0.86% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 10.1% | O: -1.77% H: 0.46% C: 0.41%
AMGN | $269.03 2.39% 2.33% 3.4M

| -7.62% | O: -0.4% H: 1.6% C: 1.54%
report health treatment care global market

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| 1.76% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

| -9.04% | O: 0.09% H: 0.39% C: -0.36%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -4.79% | O: 0.43% H: 0.67% C: 0.21%
BAX | $39.47 -0.45% 0.0% 2.8M

| -0.6% | O: 0.21% H: 0.24% C: -1.04%
ABBV | $166.41 1.06% 0.0% 5.5M

| -2.7% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -0.49% | O: 1.33% H: 0.0% C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M

| -1.3% | O: -0.38% H: 1.79% C: 0.22%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 2.25% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $269.03 2.39% 2.33% 3.4M

| -14.91% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K

| -12.32% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

| 1.76% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

| 38.0% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.47 -1.11% 520K

| -12.76% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M

| -6.5% | O: 0.07% H: 0.42% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M

| -9.04% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -5.03% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 3.02% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.93 1.3% 0.0% 10M

| -0.67% | O: -0.14% H: 0.35% C: -1.12%
ABBV | $166.41 1.06% 0.0% 5.5M

| -2.7% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $394.43 0.24% 0.24% 1.3M

| -5.25% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -0.49% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K

| -11.84% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 2.25% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $269.03 2.39% 2.33% 3.4M

| -14.91% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $138.24 -4.19% 800

| 3.77% | O: 3.41% H: 0.0% C: -2.45%
VTRS A | $11.25 1.17% 1.16% 4.7M

| -4.74% | O: -0.08% H: 3.47% C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.43% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 1.69% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $166.41 1.06% 0.0% 5.5M

| 0.9% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -7.9% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K

| 5.14% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 2.01% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $269.03 2.39% 2.33% 3.4M

| -14.52% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

n/a

| -11.05% | O: -1.84% H: 0.52% C: 0.52%
CSLLY | $86.918 3.3% 60K

n/a

| -10.72% | O: -0.25% H: 1.0% C: 0.98%
ALPMF | $9.17 43.47% 16K

| -14.1% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
AZNCF | News | $138.24 -4.19% 800

| 2.81% | O: 3.1% H: 0.0% C: -3.91%
ALPMY | $9.47 -1.11% 520K

| -18.1% | O: -3.53% H: 3.49% C: 3.4%
TVTX | $5.73 -1.21% -1.22% 950K

| -38.63% | O: -1.39% H: 0.16% C: -1.96%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 1.77% | O: 0.26% H: 0.13% C: -0.18%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 2.02% | O: 0.24% H: 0.01% C: -0.22%
AMGN | $269.03 2.39% 2.33% 3.4M

| -14.2% | O: -0.29% H: 0.76% C: 0.67%
companies renal anemia key therapeutics growth market

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -8.68% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $138.24 -4.19% 800

| 3.34% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | $93.6375 6.88% 82K

| -12.49% | O: 1.4% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

| -1.32% | O: -0.18% H: 2.37% C: 2.28%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.82% | O: 0.12% H: 0.39% C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M

| 1.95% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.64% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 3.02% | O: 1.8% H: 0.14% C: -0.89%
AMGN | $269.03 2.39% 2.33% 3.4M

| -12.63% | O: 0.29% H: 1.12% C: 0.47%
research growth market

Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published: 2024-01-12 (Crawled : 11:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| -0.6% | O: 2.07% H: 0.0% C: -0.06%
ERAS | $1.79 0.0% 570K

| -8.21% | O: 0.0% H: 4.62% C: -1.03%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.3% | O: -0.16% H: 0.43% C: 0.02%
AZN | News | $68.56 0.29% 0.29% 4.7M

| -0.91% | O: 0.25% H: 0.36% C: 0.1%
AMGN | $269.03 2.39% 2.33% 3.4M

| -11.27% | O: 0.71% H: 0.56% C: 0.42%
melanoma research global market

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 3.48% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

| -8.98% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | News | $138.24 -4.19% 800

| -0.62% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | $93.6375 6.88% 82K

| -10.82% | O: -0.24% H: 1.43% C: 1.43%
NVS | $94.36 1.93% 0.0% 2.3M

| -10.62% | O: 0.32% H: 0.93% C: 0.38%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 1.74% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.23% | O: -0.14% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| -0.33% | O: -0.68% H: 0.87% C: 0.1%
AMGN | $269.03 2.39% 2.33% 3.4M

| -11.29% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -3.25% | O: 3.66% H: 0.0% C: -0.12%
AZNCF | News | $138.24 -4.19% 800

| 4.37% | O: 3.33% H: 0.0% C: -2.93%
NVO | News | $122.71 -0.03% 0.17% 5M

| 18.58% | O: -0.31% H: 0.39% C: -0.44%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -3.65% | O: 1.09% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 26.98% | O: 0.18% H: 0.5% C: -0.46%
BMY | $48.93 1.3% 0.0% 10M

| -4.55% | O: -0.78% H: 5.15% C: 2.81%
ABBV | $166.41 1.06% 0.0% 5.5M

| 9.06% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -4.99% | O: 1.03% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

| 6.53% | O: 0.52% H: 0.58% C: 0.05%
GILD | $66.77 0.92% 0.91% 11M

| -15.42% | O: 0.34% H: 1.02% C: 0.59%
BIIB | $194.39 2.03% 1.99% 1.6M

| -23.43% | O: 0.57% H: 1.36% C: 1.04%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 3.39% | O: 1.06% H: 0.18% C: -1.06%
AMGN | $269.03 2.39% 2.33% 3.4M

| -3.72% | O: 0.24% H: 2.03% C: 1.49%
patent report global market

Proton Pump Inhibitors (PPIs) Market to grow by USD 807.89 million from 2023-2028 | North America to account for 36% of market growth - Technavio
Published: 2023-12-19 (Crawled : 07:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| 6.41% | O: 3.81% H: 0.0% C: 0.0%
BHC | $8.69 1.05% 0.0% 2.9M

| 17.91% | O: 1.22% H: 1.88% C: 0.94%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -4.44% | O: 0.45% H: 0.0% C: 0.0%
RDHL | $0.4519 7.39% 6.88% 330K

| -63.11% | O: 0.82% H: 8.94% C: 7.32%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 3.94% | O: -0.5% H: 0.99% C: 0.43%
AMGN | $269.03 2.39% 2.33% 3.4M

| -2.38% | O: 1.17% H: 0.67% C: -0.09%
america growth market

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| 8.79% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | $93.6375 6.88% 82K

| -2.46% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $544.78 0.6% 0.0% 1.7M

| 10.88% | O: 0.86% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

| -3.0% | O: 0.45% H: 0.75% C: 0.46%
ABBV | $166.41 1.06% 0.0% 5.5M

| 10.32% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -1.92% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 7.95% | O: 1.54% H: 0.06% C: -0.78%
AMGN | $269.03 2.39% 2.33% 3.4M

| -1.18% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 14.06% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $138.24 -4.19% 800

| 8.31% | O: 1.51% H: 0.13% C: -1.68%
NVS | $94.36 1.93% 0.0% 2.3M

| -2.69% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 9.41% | O: -0.03% H: 0.28% C: -0.41%
BAX | $39.47 -0.45% 0.0% 2.8M

| 10.25% | O: 0.14% H: 0.78% C: 0.22%
ABBV | $166.41 1.06% 0.0% 5.5M

| 15.11% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 7.09% | O: 0.73% H: 0.06% C: -1.38%
AMGN | $269.03 2.39% 2.33% 3.4M

| -0.72% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News S | $154.08 -1.24% -1.25% 32M

| 19.45% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News S | $155.7 -1.12% -1.13% 20M

| 19.44% | O: 1.97% H: 0.0% C: 0.0%
ADBE | News A | $465.03 -1.72% -1.75% 3M

| -22.78% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

← Previous
1
2
3
4
5
Next →

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

Finance

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

NVFY | $2.77 31.28% 23.83% 33M

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K